Acromegaly
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients with Acromegaly
Exclusion criteria
Exclusion criteria: 1. Patients with bone metabolic disease 2. Patients treated at present or within 12 months with bisphosphonate, teriparatide, anti-RANKL Ab, and romosozumab. 3. Patients administered with steroids. 4. Patients complicated with malignancy. 5. Pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone microstructure and metabolic markers compared to those of healthy control | — |
Countries
Japan
Contacts
Nagasaki University Hospital Department of Endocrinology and Metabolism